Who is sponsoring NCT05434052?

NCT05434052 is sponsored by Istanbul Medeniyet University.

What drugs are being tested in NCT05434052?

Interventions in NCT05434052: Turkish Validity and Reliability of The CIQ-R Scale.

What condition does NCT05434052 study?

NCT05434052 studies Stroke, Community Integration.

Is NCT05434052 still recruiting?

NCT05434052 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT05434052

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Turkish Adaptation, Validity and Reliability of Community Integration Questionnaire-Revised (CIQ-R)

Completed Last updated 5 October 2023

What this trial tests

trial testing Turkish Validity and Reliability of The CIQ-R Scale in Stroke in 130 participants. Completed in 5 September 2023.

Timeline

3 May 2022

Primary endpoint
30 August 2023

5 September 2023

Quick facts

Lead sponsor	Istanbul Medeniyet University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	130
Start date	3 May 2022
Primary completion	30 August 2023
Estimated completion	5 September 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Turkish Validity and Reliability of The CIQ-R Scale

Conditions studied

Stroke — all drugs for Stroke →
Community Integration — all drugs for Community Integration →

Sponsor

Istanbul Medeniyet University

Who can join

Adults 18 to 65, any sex, with Stroke or Community Integration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to adapt the Community Integration Questionnaire-Revised (CIQ-R) scale to Turkish society and to make its validity and reliability in Turkish. The CIQ-R scale developed by Callaway et al assesses home integration, social integration, productivity, and electronic social networking in neurological diseases. It has 18 questions. This study will be conducted with stroke patients. The patients will be sought to answer questionnaires during regular rehabilitation sessions. 130 participants will be included in the study. In order to evaluate the validity of the CIQ-R, the Mini Mental State Examination (MMSE), which can evaluates general cognitive functioning and has been validated in Turkish, will be used. Scales will be repeated after 15 days to assess test-retest reliability.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Istanbul Medeniyet University trials

Trials by the same sponsor.

NCT07478380 — Transcutaneous pO₂ Monitoring in PICU · recruiting
NCT07368244 — Turkish Translation and Content Validity of the Nottwil Environmental Factors Inventory (NEFI) in Persons With Spinal Co · recruiting
NCT07179731 — Comparison of the Effects of External Oblique Intercostal Plane Block, Subcostal Transverse Abdominis Plane Block, and T · NA · not yet recruiting
NCT07241455 — Validity of the Children's Chelsea Critical Care Physical Assessment Tool (cCPAx-TR) in Turkish Pediatric Intensive Care · completed
NCT07426497 — Osteopathic Manual Therapy vs Ganglion Impar Block for Chronic Coccydynia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05434052 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medeniyet University
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05434052.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing